引用本文:陈锦宏.优泌乐50治疗初诊2型糖尿病的临床体会[J].中国临床新医学,2011,4(1):70-71.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1508次   下载 1007 本文二维码信息
码上扫一扫!
分享到: 微信 更多
优泌乐50治疗初诊2型糖尿病的临床体会
陈锦宏
530300 广西,横县人民医院内分泌科
摘要:
[摘要] 目的 探讨优泌乐50治疗初诊2型糖尿病的临床疗效。方法 选取初诊2型糖尿病患者80例,使用优泌乐50治疗12周,比较治疗前后空腹血糖、餐后2 h血糖、糖化血红蛋白、空腹胰岛素、胰岛素分泌指数、胰岛素抵抗指数的变化。结果 治疗后空腹血糖、餐后2 h血糖、糖化血红蛋白、胰岛素抵抗指数较治疗前明显下降(P<0.05);空腹胰岛素、胰岛素分泌指数明显升高(P<0.01)。结论 应用优泌乐50治疗能显著降低初诊2型糖尿病患者血糖和改善胰岛功能。
关键词:  优泌乐50  2型糖尿病
DOI:10.3969/j.issn.1674-3806.2011.01.28
分类号:R 587.1
基金项目:
Clinical experience of Humalog Mix50 in the treatment of patients with newly diagnosed type 2 diabetes mellitus
CHEN Jin-hong
Department of Endocrinology, Hengxian People′s Hospital,Guangxi 530300,China
Abstract:
[Abstract] Objective To investigate the effect of Humalog Mix50 in the treatment of the patients with newly diagnosed type 2 diabetes mellitus. Methods Eighty patients with newly diagnosed type 2 diabetes mellitus were treated with Humalog Mix50 for 12 weeks. Fasting and 2-hour postprandial blood glucose, glycosylated hemoglobin, fast insulin, insulin secretion index and insulin resistance index were measured before and after treatment. Results Compared with those before treatment, fasting blood glucose, 2-hour postprandial blood glucose, glycosylated hemoglobin, insulin resistance index decreased significantly after treatment(P<0.05), while fast insulin, insulin secretion index increased significantly after treatment(P<0.01). Conclusion Humalog Mix50 therapy can improve blood glucose control and insulin secretion function in the patients with newly diagnosed type 2 diabetic patients.
Key words:  Humalog Mix50  Type 2 diabetes mellitus